Surgery Partners, Inc. (SGRY) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	3.4B	3.3B	3.1B	2.7B	2.5B
Cost of Revenue	2.6B	2.5B	2.4B	2.1B	2.0B
Gross Profit	719.4M	765.0M	745.6M	647.5M	574.9M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	627.5M	522.7M	138.7M	120.9M	102.2M
General & Admin Expense	627.5M	522.7M	138.7M	120.9M	102.2M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	(308.5M)	(147.2M)	258.1M	198.6M	127.5M
Total Operating Expenses	319.0M	375.5M	396.8M	319.5M	229.7M
Cost and Expenses	3.0B	2.9B	2.8B	2.4B	2.2B
Operating Income (EBIT)	400.4M	389.5M	348.8M	328.0M	345.2M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	668.0M	272.6M	201.7M	193.0M	234.9M
Net Interest Income	(668.0M)	(272.6M)	(201.7M)	(193.0M)	(234.9M)
Other Non-Op Income/Expense	(298.0M)	(272.6M)	(201.7M)	(193.0M)	(234.9M)
Non-Operating Income (excl Interest)	(370.0M)	—	—	—	—
EBT (Pre-Tax Income)	102.4M	116.9M	147.1M	135.0M	110.3M
Income Tax Expense	20.5M	18.0M	134.6M	(300.0K)	23.3M
Bottom Line
Net Income	(88.6M)	(77.9M)	(168.1M)	(11.9M)	(54.6M)
Earnings from Cont. Ops	81.9M	98.9M	12.5M	135.3M	87.0M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(88.6M)	(77.9M)	(168.1M)	(11.9M)	(54.6M)
Per Share
Basic EPS	($0.69)	($0.61)	($1.33)	($0.09)	($0.59)
Diluted EPS	($0.69)	($0.61)	($1.33)	($0.09)	($0.59)
Revenue Per Share	$26.13	$26.01	$24.69	$21.84	$27.62
Shares
Basic Shares Outstanding	128.8M	127.2M	126.1M	125.6M	92.0M
Diluted Shares Outstanding	128.8M	127.2M	126.1M	125.6M	92.0M
Profitability Metrics
EBITDA	947.6M	565.5M	501.4M	446.1M	460.0M
D&A	177.2M	176.0M	152.6M	118.1M	114.8M
EBIT	770.4M	389.5M	348.8M	328.0M	345.2M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026